FUM logo

Futura Medical plc Stock Price

AIM:FUM Community·UK£9.0m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 20 Fair Values set on narratives written by author

FUM Share Price Performance

UK£0.015
-0.29 (-94.90%)
UK£0.015
-0.29 (-94.90%)
Price UK£0.015

FUM Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet and fair value.

3 Risks
1 Reward

Futura Medical plc Key Details

UK£7.9m

Revenue

UK£2.8m

Cost of Revenue

UK£5.1m

Gross Profit

UK£11.4m

Other Expenses

-UK£6.3m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-0.011
64.49%
-79.41%
0%
View Full Analysis

About FUM

Founded
2001
Employees
14
CEO
Alex Duggan
WebsiteView website
www.futuramedical.com

Futura Medical plc research, develops, and commercializes pharmaceutical and healthcare products for sexual health. The company’s lead product includes Eroxon, a topical gel for the treatment of erectile dysfunction. It also develops WSD4000 for the treatment of sexual dysfunction in women. The company operates in the United Kingdom, the European Union, the United States, and internationally. Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.

Recent FUM News & Updates

Recent updates

No updates